Trusted Resources: Education
Scientific literature and patient education texts
Damage of the Cardiovascular System in Lysosomal Storage Disease – Mucopolysaccharidosis
source: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
year: 2021
authors: Pyvovar SM,Rudyk IS,Lozykc TV
summary/abstract:The analysis of literature data reflecting the issues of the pathology of the cardiovascular system in mucopolysaccharidosis are presented. It was found out that heart and vessels damage is one of the cardinal signs of this pathology, often leading to death. Cardiac pathology is recorded in all types of mucopolysaccharidosis, but it is most significant for patients with three clinical variants of Hurler syndrome, Hunter, and Maroteaux-Lamy syndromes. Typical signs of damage to the cardiovascular system in mucopolysaccharidosis are thickening of the valves with the development of their dysfunction (while the severity of damage to the left-sided valves is more pronounced), myocardial hypertrophy, conduction disturbance, coronary artery disease, arterial hypertension. Many researchers emphasize the difficulties of clinical and functional examination of the cardiovascular system in patients with mucopolysaccharidosis, which is due to the presence of physical and intellectual limitations in patients, ands a gradual increase in symptoms. For the treatment of cardiovascular pathology at mucopolysaccharidosis, medical and surgical methods are used, including enzyme replacement therapy and stem cell transplantation.
organization: Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine", Kharkiv, Ukraine.DOI: 16;49(294):448-452
read more
Related Content
-
Walla Al-Hertani, MD, MS, FRCPC, FCCMG, FACMGDr. Walla Al-Hertani is a Medical Bioche...
-
Clinical Outcomes of Laminoplasty for Patients With Lysosomal Storage Disease Including Mucopolysaccharidosis and Mu...Although the clinical efficacy of lamino...
-
Magnetic Resonance Imaging Findings of the Posterior Fossa in 47 Patients With Mucopolysaccharidoses: A Cross-Sectio...Mucopolysaccharidoses (MPS) is a group o...
-
Emotional Responses to Diagnosis of MPS or MLIf you or someone you know have been dia...
-
Inhibition of Iduronic Acid Biosynthesis by Ebselen Reduces Glycosaminoglycan Accumulation in Mucopolysaccharidosis ...Mucopolysaccharidosis type I (MPS-I) is ...
-
Novel Subtype of Mucopolysaccharidosis Caused by Arylsulfatase K (ARSK) DeficiencyMucopolysaccharidoses (MPS) are monogeni...
-
Real-World Data Assessment of Safety of Home-Based and Hospital/Outpatient-Based laronidase Enzyme Replacement Thera...Enzyme replacement therapy (ERT) is avai...